US and China Medical Device Premarket Application Comparison

US and China Medical Device Premarket Application Comparison

Actions and Detail Panel

Free

Date and time

Location

Online event

Learn about regulatory pathways in the US and China

About this event

Although the US and China medical device markets offer the greatest opportunities for revenues, many wonder if the regulatory hurdles are worth taking and if one path is more complex than the other. In this brief review, CUBIO advisor Margaret Wong will give a glimpse of the similarities and differences between the medical device premarket regulatory pathways between US and China. Included are some common mistakes that companies should avoid when pursuing regulatory approval of their products for commercialization.

Share with friends